Opus Genetics, Inc. — Investor Relations & Filings
Filings indexed
978
across all filing types
Latest filing
2026-04-24
Regulatory Filings
Country
US
United States of America
Listing
US
IRD
Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company that develops gene therapies to treat inherited retinal diseases (IRDs) and other retinal disorders. The company focuses on advancing treatments that address genetic mutations causing vision loss. Its pipeline targets conditions such as Leber congenital amaurosis (LCA), bestrophinopathy (Best disease), and retinitis pigmentosa (RP). The company's primary mission is to restore vision and prevent blindness by creating an efficient path to bring new therapies to the clinic for patients with inherited blinding conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-24 | English | |
| 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-22 | English | |
| 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-07 | English | |
| 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | |
| 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | |
| 8-K - OPUS GENETICS, INC. (0001228627) (Filer) | 2026-02-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36294315 | 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-24 | English | ||
| 35205472 | 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-22 | English | ||
| 33703027 | 8-K - Opus Genetics, Inc. (0001228627) (Filer) | 2026-04-07 | English | ||
| 32979245 | 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | ||
| 32979139 | 4 - Opus Genetics, Inc. (0001228627) (Issuer) | 2026-03-18 | English | ||
| 32889041 | 8-K - OPUS GENETICS, INC. (0001228627) (Filer) | 2026-02-19 | English | ||
| 32889040 | 4 - OPUS GENETICS, INC. (0001228627) (Filer) | 2026-02-17 | English | ||
| 28479870 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 28480001 | 4 Filing | 2026-01-26 | English | ||
| 28479961 | 4 Filing | 2026-01-26 | English | ||
| 28479923 | 4 Filing | 2026-01-26 | English | ||
| 28479847 | 4 Filing | 2026-01-26 | English | ||
| 28479839 | 4 Filing | 2026-01-26 | English | ||
| 28479790 | 4 Filing | 2026-01-26 | English | ||
| 28479892 | S-8 Filing | 2026-01-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ArcticZymes Technologies
Develops and manufactures novel recombinant enzymes from Ar…
|
AZT | NO | Manufacturing |
|
Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare a…
|
ARCT | US | Manufacturing |
|
Arcus Biosciences, Inc.
A clinical-stage biopharmaceutical company developing combi…
|
RCUS | US | Manufacturing |
|
Arcutis Biotherapeutics, Inc.
Develops and commercializes treatments for immune-mediated …
|
ARQT | US | Manufacturing |
|
ARDELYX, INC.
Biopharmaceutical company developing medicines for cardiore…
|
ARDX | US | Manufacturing |
|
ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its prop…
|
AREC | GB | Manufacturing |
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
Opus Genetics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34149/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34149 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34149 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34149 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34149}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Opus Genetics, Inc. (id: 34149)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.